Phase II study of vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in patients with advanced transitional cell urothelial cancer (TCC) after platinum-based therapy—California Cancer Consortium/University of Pittsburgh NCI/CTEP-sponsored trial
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. M. Cheung, D. I. Quinn, D. D. Tsao-Wei, S. G. Groshen, A. M. Aparicio, P. Twardowski, G. S. Chatta, P. N. Lara, D. R. Gandara
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591406357